SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (1230)7/15/2005 3:36:00 PM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
CNCT Is trying to close its June 13 downgap. (Its April 27 downgap is a different subject.<g>)

The insiders have continued selling and the earning were down in the 1st Q 49% ($0.03/shr vs. $0.05/shr in 2004)while revenues increased around 70% ( 42.4M vs. 25M)

It cut its earnings guidance last month to around $0.57/shr in 2005 but EE for 2006 are still above $1.

CNCT reportedly has around $ 6.70 in cash/shr. It has a large
LTD and its Debt/Equt is around 3.04 but it reportedly had a cash flow from operations around $37M and an even larger FCF ? <g>

The stock has been up almost 4% today.<g>

bigcharts.marketwatch.com

Bernard



To: Jibacoa who wrote (1230)9/12/2005 1:44:59 PM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
CELG Is also presenting at the Bear Stearns Health Conference in NY today.

The stock is making another 52 wks, H and volume has expanded already to 5,605,100

bigcharts.marketwatch.com

Bernard